PDE2A and nervous system disorder: Besides further PDE2A inhibitors developed for treatment of neurological disorders [3,29,30,31,32,33,34,35], two PDE2A radioligands for molecular imaging of this protein in the brain via positron emission tomography (PET) have been reported to date (Figure 2).